Ngenla 24 mg – Pfizer – Australia
Price range: $650.00 through $5,200.00
| MANUFACTURER | Ultima Pharmaceuticals – US |
| WAREHOUSE | USA Warehouse 5 |
| SUBSTANCE | GHRH Peptide, |
Ngenla 24 mg – Pfizer – Australia
Ngenla 24 mg – Pfizer – Australia is a once-weekly long-acting growth hormone therapy containing somatrogon, developed by Pfizer for the treatment of pediatric growth hormone deficiency (GHD). Unlike traditional daily HGH injections, Ngenla’s advanced extended-release formula supports stable growth hormone levels with fewer injections, improving convenience and adherence for children from 3 years of age and older with insufficient natural growth hormone production. The 24 mg disposable prefilled pen delivers precise, adjustable weekly dosing via subcutaneous injection, supporting height velocity, metabolic function, and normal growth progression when prescribed by a healthcare professional. Requires prescription and medical supervision.
| Size |
1 Pack (1 pen x 24 mg / 1.2 ml) ,10 Pack (1 pen x 24 mg / 1.2 ml) ,5 Pack (1 pen x 24 mg / 1.2 ml) |
|---|
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.